Search results
SK Bioscience chief says unlikely China will source vaccines from it - FT
Reuters via Yahoo News· 1 year agoAhn said that it was "unrealistic" to supply COVID vaccines to China, as the country insists on...
SK Hynix to break ground on new U.S. chip packaging plant early next year -sources
Reuters via Yahoo Finance· 2 years agoWASHINGTON (Reuters) -South Korea's SK Hynix aims to select a U.S. site for its advanced chip...
Biden welcomes SK Group plans to invest $22 billion in U.S. high-tech sectors
Reuters via Yahoo Finance· 2 years agoWASHINGTON (Reuters) -President Joe Biden on Tuesday welcomed plans from South Korea's...
China is still racing to develop its own mRNA jabs. But they won't use foreign vaccines to fight...
Business Insider via Yahoo News· 1 year agoChinese officials say domestically developed COVID-19 vaccines are effective.CFOTO/Future...
S.Korea approves first domestically developed COVID vaccine
Reuters via Yahoo News· 2 years agoSouth Korea approved its first domestically developed COVID-19 vaccine, manufactured by SK...
False claim UK approved plan to spray COVID-19 vaccines from airplanes | Fact check
USA TODAY via Yahoo News· 12 months agoThe claim: UK government approved plan to forcibly vaccinate citizens using aerosolized COVID-19...
Korean firm's $22B investment will mean new US jobs, WH says
Associated Press via Yahoo News· 2 years agoSouth Korea's SK Group on Tuesday announced plans to invest $22 billion in the United States on...
UPDATE 2-SK Group plans $22 bln investment in U.S. high-tech sectors
Reuters via Yahoo Finance· 2 years agoSouth Korea's second-largest conglomerate SK Group on Tuesday said it plans $22 billion in new investments in the United States, in semiconductors, green energy and bioscience projects. SK Group ...
South Korean chip maker SK Hynix reports record revenue despite 'difficult' business environment
South China Morning Post via Yahoo Finance· 2 years agoSouth Korean memory chip giant SK Hynix said it achieved record-high revenue in the second quarter...
Novavax to sell 7% stake to South Korea's SK Bioscience
Reuters via AOL· 10 months ago(Reuters) -SK Bioscience is taking a roughly 7% stake in Novavax in lieu of some payment owed to the South Korean biotech company, giving the cash-strapped COVID-19 vaccine maker some breathing ...
